HuGE Literature Finder
Records 1-30
|
Mutation profile of non-small cell lung cancer revealed by next generation sequencing.
Respiratory research 2021 Jan 22 (1): 3. Chang Ya-Sian, Tu Siang-Jyun, Chen Yu-Chia, Liu Ting-Yuan, Lee Ya-Ting, Yen Ju-Chen, Fang Hsin-Yuan, Chang Jan-Gow |
|
Clinical Application of the FoundationOne CDx Assay to Therapeutic Decision-Making for Patients with Advanced Solid Tumors.
The oncologist 2020 Dec . Takeda Masayuki, Takahama Takayuki, Sakai Kazuko, Shimizu Shigeki, Watanabe Satomi, Kawakami Hisato, Tanaka Kaoru, Sato Chihiro, Hayashi Hidetoshi, Nonagase Yoshikane, Yonesaka Kimio, Takegawa Naoki, Okuno Tatsuya, Yoshida Takeshi, Fumita Soichi, Suzuki Shinichiro, Haratani Koji, Saigoh Kazumasa, Ito Akihiko, Mitsudomi Tetsuya, Handa Hisashi, Fukuoka Kazuya, Nakagawa Kazuhiko, Nishio Kazu |
|
Comprehensive genomic profiling of Brazilian non-small cell lung cancer patients (GBOT 0118/LACOG0418).
Thoracic cancer 2020 Dec . Mascarenhas Eldsamira, Gelatti Ana Caroline, Araújo Luiz Henrique, Baldotto Clarissa, Mathias Clarissa, Zukin Mauro, Werutsky Gustavo, Pacheco Patricia, Gomes Rafaela, de Castro Gilberto, de Lima Vladmir Cordei |
|
Genetic Heterogeneity of MET-aberrant Non-Small Cell Lung Cancer and its Impact on the Outcome of Immunotherapy.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2020 Dec . Kron A, Scheffler M, Heydt C, Ruge L, Schaepers C, Eisert A, Merkelbach-Bruse S, Riedel R, Nogova L, Fischer R N, Michels S, Abdulla D S Y, Koleczko S, Fassunke J, Schultheis A M, Kron F, Ueckeroth F, Wessling G, Sueptitz J, Beckers F, Braess J, Panse J, Grohé C, Hamm M, Kabitz H-J, Kambartel K, Kaminsky B, Krueger S, Schulte C, Lorenz J, Lorenzen J, Meister W, Meyer A, Kappes J, Reinmuth N, Schaaf B, Schulte W, Serke M, Buettner R, Wolf |
|
Genotype-specific differences in circulating tumor DNA levels in advanced NSCLC.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2020 Dec . Lam Vincent K, Zhang Jianjun, Wu Carol C, Tran Hai T, Li Lerong, Diao Lixia, Wang Jing, Rinsurongkawong Waree, Raymond Victoria M, Lanman Richard B, Lewis Jeff, Roarty Emily B, Roth Jack, Swisher Stephen, Lee J Jack, Gibbons Don L, Papadimitrakopoulou Vassiliki A, Heymach John |
|
Lung cancer pathogenesis and poor response to therapy were dependent on driver oncogenic mutations.
Life sciences 2020 Dec 118797. Sun Xin, Li Kai, Zhao Rui, Sun Ye, Xu Jie, Peng Zi-Yang, Song Run-Dong, Ren Hong, Tang Shou-Chi |
|
Osimertinib for Chinese advanced non-small cell lung cancer patients harboring diverse EGFR exon 20 insertion mutations.
Lung cancer (Amsterdam, Netherlands) 2020 Dec 152 39-48. Yang Guang-Jian, Li Jun, Xu Hai-Yan, Sun Yang, Liu Liu, Li Hong-Shuai, Yang Lu, Zhang Yuan, Li Guo-Hui, Wang Y |
|
Comprehensive genomic profile of Chinese lung cancer patients and mutation characteristics of individuals resistant to icotinib/gefitinib.
Scientific reports 2020 Nov 10 (1): 20243. Shang Yanhong, Li Xiaofang, Liu Weiwei, Shi Xiaoliang, Yuan Shaohua, Huo Ran, Fang Guotao, Han Xiao, Zhang Jingnan, Wang Kunjie, Dou Zhengyue, Zhang Yan, Zang Aimin, Zhang L |
|
Longitudinal therapy monitoring of ALK-positive lung cancer by combined copy number and targeted mutation profiling of cell-free DNA.
EBioMedicine 2020 Nov 62 103103. Dietz Steffen, Christopoulos Petros, Yuan Zhao, Angeles Arlou Kristina, Gu Lisa, Volckmar Anna-Lena, Ogrodnik Simon J, Janke Florian, Fratte Chiara Dalle, Zemojtel Tomasz, Schneider Marc A, Kazdal Daniel, Endris Volker, Meister Michael, Muley Thomas, Cecchin Erika, Reck Martin, Schlesner Matthias, Thomas Michael, Stenzinger Albrecht, Sültmann Holg |
|
PDL1 high expression without TP53, KEAP1 and EPHA5 mutations could better predict survival for patients with NSCLC receiving atezolizumab.
Lung cancer (Amsterdam, Netherlands) 2020 Nov . Wang Haiyong, Shan Qinge, Guo Jun, Han Xiao, Zhao Chenglong, Li Huijuan, Wang Zheh |
|
Predictive and Prognostic Potential of TP53 in Patients With Advanced Non-Small-Cell Lung Cancer Treated With EGFR-TKI: Analysis of a Phase III Randomized Clinical Trial (CTONG 0901).
Clinical lung cancer 2020 Nov . Li Xiang-Meng, Li Wen-Feng, Lin Jun-Tao, Yan Hong-Hong, Tu Hai-Yan, Chen Hua-Jun, Wang Bin-Chao, Wang Zhen, Zhou Qing, Zhang Xu-Chao, Su Jian, Chen Rui-Lian, Wu Yi-Long, Yang Jin- |
|
Molecular and clinicopathological characteristics of ROS1-rearranged non-small cell lung cancers identified by next generation sequencing.
Molecular oncology 2020 Sep . Cui Meiying, Han Yuchen, Li Pan, Zhang Jianying, Ou Qiuxiang, Tong Xiaoling, Zhao Ruiying, Dong Nan, Wu Xue, Li Wencai, Jiang Guozho |
|
Patients with advanced non-small cell lung cancer with EGFR mutations in addition to complex mutations treated with osimertinib have a poor clinical outcome: A real-world data analysis.
Oncology letters 2020 Sep 20 (3): 2266-2272. Chang Nijia, Duan Jingjing, Wang Lingxiong, Dong Zhouhuan, Liu Zhefe |
|
Plasma-based longitudinal mutation monitoring as a potential predictor of disease progression in subjects with adenocarcinoma in advanced non-small cell lung cancer.
BMC cancer 2020 Sep 20 (1): 885. Jiang John, Adams Hans-Peter, Lange Maria, Siemann Sandra, Feldkamp Mirjam, McNamara Sylvie, Froehler Sebastian, Yaung Stephanie J, Yao Lijing, Balasubramanyam Aarthi, Tikoo Nalin, Ju Christine, Achenbach H Jost, Krügel Rainer, Palma John |
|
Prevalence and potential biologic role of TERT amplifications in ALK-translocated adenocarcinoma of the lung.
Histopathology 2020 Sep . Alidousty Christina, Duerbaum Nicolai, Wagener-Ryczek Svenja, Baar Till, Martelotto Luciano Gaston, Heydt Carina, Siemanowski Janna, Holz Barbara, Binot Elke, Fassunke Jana, Merkelbach-Bruse Sabine, Wolf Juergen, Kron Anna, Buettner Reinhard, Maria Schultheis An |
|
Association of Cerebrospinal Fluid Tumor DNA Genotyping With Survival Among Patients With Lung Adenocarcinoma and Central Nervous System Metastases.
JAMA network open 2020 Aug 3 (8): e209077. Li Yang-Si, Zheng Mei-Mei, Jiang Ben-Yuan, Tu Hai-Yan, Yang Jin-Ji, Zhang Xu-Chao, Wu Yi-Lo |
|
Characterization of MET exon 14 alteration and association with clinical outcomes of crizotinib in Chinese lung cancers.
Lung cancer (Amsterdam, Netherlands) 2020 Aug 148 113-121. Yang Haiyan, Zhou Zhen, Lin Li, Yang Mingxia, Li Chong, Li Ziming, Yu Xinmin, Lizaso Analyn, Han-Zhang Han, Li Bing, Xiang Jianxing, Mao Xinru, Xu Qinqin, Zhang Yongchang, Yang No |
|
Impact of genetic alterations on outcomes of patients with stage I nonsmall cell lung cancer: An analysis of the cancer genome atlas data.
Cancer medicine 2020 Aug . Xu Song, Wang Yanye, Ren Fan, Li Xiongfei, Ren Dian, Dong Ming, Chen Gang, Song Zuoqing, Chen J |
|
Risk stratification of EGFR
Lung cancer (Amsterdam, Netherlands) 2020 Aug 148 105-112. Christopoulos P, Kirchner M, Roeper J, Saalfeld F, Janning M, Bozorgmehr F, Magios N, Kazdal D, Volckmar A L, Brückner L M, Bochtler T, Kriegsmann M, Endris V, Penzel R, Kriegsmann K, Eichhorn M, Herth F J F, Heussel C P, El Shafie R A, Schneider M A, Muley T, Meister M, Faehling M, Fischer J R, Heukamp L, Schirmacher P, Bischoff H, Wermke M, Loges S, Griesinger F, Stenzinger A, Thomas |
|
TP53 Arg72Pro and XPD Lys751Gln Gene Polymorphisms and Risk of Lung Cancer in Bangladeshi Patients.
Asian Pacific journal of cancer prevention : APJCP 2020 Jul 21 (7): 2091-2098. Nairuz Tahsin, Rahman Mostafijur, Bushra Most Umme, Kabir Year |
|
Acquired resistance to osimertinib in patients with non-small-cell lung cancer: mechanisms and clinical outcomes.
Journal of cancer research and clinical oncology 2020 May . Mu Yuxin, Hao Xuezhi, Xing Puyuan, Hu Xingsheng, Wang Yan, Li Teng, Zhang Jinyao, Xu Ziyi, Li Junli |
|
[Genetic Profile of Young Chinese Patients with Lung Adenocarcinoma].
Zhongguo fei ai za zhi = Chinese journal of lung cancer 2020 Apr 23 (4): 239-246. Liang Yu, Hou Helei, Jiang Man, Zhang Chuantao, Liu Dong, Zhang Xiaoch |
|
Target-based genomic profiling of ctDNA from Chinese non-small cell lung cancer patients: a result of real-world data.
Journal of cancer research and clinical oncology 2020 Mar . Chen Huijuan, Wang Aiqin, Wang Jing, He Zeming, Mao Yanqiu, Liu Limi |
|
Impact of somatic mutations on prognosis in resected non-small-cell lung cancer: The Japan Molecular Epidemiology for lung cancer study.
Cancer medicine 2020 Feb . Tamiya Akihiro, Koh Yasuhiro, Isa Shun-Ichi, Kubo Akihito, Ando Masahiko, Saka Hideo, Yoshimoto Naoki, Takeo Sadanori, Adachi Hirofumi, Tagawa Tsutomu, Kawashima Osamu, Yamashita Motohiro, Kataoka Kazuhiko, Takenoyama Mitsuhiro, Takeuchi Yukiyasu, Watanabe Katsuya, Matsumura Akihide, Kawaguchi Tomo |
|
Survival prediction for patients with lung adenocarcinoma: A prognostic risk model based on gene mutations.
Cancer biomarkers : section A of Disease markers 2020 Feb . Geng Hua, Li Shixiong, Guo Yixian, Yan Fang, Han Yuebin, Xu Meilin, Cui Yanz |
|
Validating a targeted next-generation sequencing assay and profiling somatic variants in Chinese non-small cell lung cancer patients.
Scientific reports 2020 Feb 10 (1): 2070. Jiang Ruirui, Zhang Bo, Teng Xiaodong, Hu Peizhen, Xu Sanpeng, Zheng Zuyu, Liu Rui, Tang Tingdong, Ye Fe |
|
Unique molecular features and clinical outcomes in young patients with non-small cell lung cancer harboring ALK fusion genes.
Journal of cancer research and clinical oncology 2020 Jan . Tian Panwen, Liu Yujie, Zeng Hao, Tang Yuan, Lizaso Analyn, Ye Junyi, Shao Lin, Li Yal |
|
Comprehensive Molecular Characterizations of Chinese Patients With Different Subtypes of Lung Squamous Cell Carcinoma.
Frontiers in oncology 2020 10 607130. Qian Jie, Chen Rongrong, Zhao Ruiying, Han Yuchen, Yu Yongfe |
|
Sequential Whole Exome Sequencing Reveals Somatic Mutations Associated with Platinum Response in NSCLC.
OncoTargets and therapy 2020 13 6485-6496. Guo Ao-Xiang, Xiao Fan, Shao Wei-Hua, Zhan Yan, Zhang Le, Xiong Jing, Gao Yang, Yin Ji- |
|
The Genomic Characteristics of ALK Fusion Positive Tumors in Chinese NSCLC Patients.
Frontiers in oncology 2020 10 726. Liu Shaokun, Huang Tanxiao, Liu Ming, He Wenlong, Zhao YingShen, Yang Lizhen, Long Yingjiao, Zong Dandan, Zeng Huihui, Liu Yuanyuan, Liao Wenting, Duan Jingxian, Gong Subo, Chen Shi |
- Page last reviewed:Oct 1, 2020
- Page last updated:Jan 19, 2021
- Content source: